|
1
|
Chow WH, Dong LM and Devesa SS:
Epidemiology and risk factors for kidney cancer. Nat Rev Urol.
7:245–257. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xu K, Ding Q, Fang Z, Zheng J, Gao P, Lu Y
and Zhang Y: Silencing of HIF-1alpha suppresses tumorigenicity of
renal cell carcinoma through induction of apoptosis. Cancer Gene
Ther. 17:212–222. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhao Y, Xue T, Yang X, Zhu H, Ding X, Lou
L, Lu W, Yang B and He Q: Autophagy plays an important role in
sunitinib-mediated cell death in H9c2 cardiac muscle cells. Toxicol
App Pharmacol. 248:20–27. 2010. View Article : Google Scholar
|
|
4
|
Motzer RJ, Rini BI, Bukowski RM, Curti BD,
George DJ, Hudes GR, Redman BG, Margolin KA, Merchan JR, Wilding G,
et al: Sunitinib in patients with metastatic renal cell carcinoma.
JAMA. 295:2516–2524. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chairatvit K and Ngamkitidechakul C:
Control of cell proliferation via elevated NEDD8 conjugation in
oral squamous cell carcinoma. Mol Cell Biochem. 306:163–169. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bello CL, Sherman L, Zhou J, Verkh L,
Smeraglia J, Mount J and Klamerus KJ: Effect of food on the
pharmacokinetics of sunitinib malate (SU11248), a multi-targeted
receptor tyrosine kinase inhibitor: Results from a phase I study in
healthy subjects. Anticancer Drugs. 17:353–358. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sasaki K, Tsuno NH, Sunami E, Tsurita G,
Kawai K, Okaji Y, Nishikawa T, Shuno Y, Hongo K, Hiyoshi M, et al:
Chloroquine potentiates the anti-cancer effect of 5-fluorouracil on
colon cancer cells. BMC Cancer. 10:3702010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Solomon VR and Lee H: Chloroquine and its
analogs: A new promise of an old drug for effective and safe cancer
therapies. Euro J Pharmacol. 625:220–233. 2009. View Article : Google Scholar
|
|
9
|
Flanigan RC, Campbell SC, Clark JI and
Picken MM: Metastatic renal cell carcinoma. Curr Trea Option Oncol.
4:385–390. 2003. View Article : Google Scholar
|
|
10
|
Meijer AJ and Codogno P: Regulation and
role of autophagy in mammalian cells. Int J Biochem Cell Biol.
36:2445–2462. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ng G and Huang J: The significance of
autophagy in cancer. Mol Carcinogen. 43:183–187. 2005. View Article : Google Scholar
|
|
12
|
Notte A, Leclere L and Michiels C:
Autophagy as a mediator of chemotherapy-induced cell death in
cancer. Biochem Pharmacol. 82:427–434. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Carew JS, Nawrocki ST and Cleveland JL:
Modulating autophagy for therapeutic benefit. Autophagy. 3:464–467.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Xu Y, Lu W, Yang P, Peng W, Wang C, Li M,
Li Y, Li G, Meng N, Lin H, et al: A small molecular agent YL529
inhibits VEGF-D-induced lymphangiogenesis and metastasis in
preclinical tumor models in addition to its known antitumor
activities. BMC Cancer. 15:5252015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Asoro MA, Kovar D and Ferreira PJ: In situ
transmission electron microscopy observations of sublimation in
silver nanoparticles. ACS Nano. 9:7844–7852. 2013. View Article : Google Scholar
|
|
16
|
Nanus DM, Garino A, Milowsky MI, Larkin M
and Dutcher JP: Active chemotherapy for sarcomatoid and rapidly
progressing renal cell carcinoma. Cancer. 101:1545–1551. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sunkara U, Walczak JR, Summerson L, Rogers
T, Eisenberger M, Denmeade S, Pili R, Huff CA, Sinibaldi V and
Carducci MA: A phase II trial of temozolomide and IFN-alpha in
patients with advanced renal cell carcinoma. J Interf Cytok Res.
24:37–41. 2004. View Article : Google Scholar
|
|
18
|
Czarnecka AM, Szczylik C and Rini B: The
use of sunitinib in renal cell carcinoma: Where are we now? Expert
Rev Anticancer Ther. 14:983–999. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Motzer RJ, Hutson TE, Tomczak P,
Michaelson MD, Bukowski RM, Oudard S, Negrier S, Szczylik C, Pili
R, Bjarnason GA, et al: Overall survival and updated results for
sunitinib compared with interferon alfa in patients with metastatic
renal cell carcinoma. J Clin Oncol. 27:3584–3590. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Milano V, Piao Y, LaFortune T and de Groot
J: Dasatinib-induced autophagy is enhanced in combination with
temozolomide in glioma. Mol Cancer ther. 8:394–406. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li J, Hou N, Faried A, Tsutsumi S and
Kuwano H: Inhibition of autophagy augments 5-fluorouracil
chemotherapy in human colon cancer in vitro and in
vivo model. Euro J Cancer. 46:1900–1909. 2010. View Article : Google Scholar
|
|
22
|
Sui X, Chen R, Wang Z, Huang Z, Kong N,
Zhang M, Han W, Lou F, Yang J, Zhang Q, et al: Autophagy and
chemotherapy resistance: A promising therapeutic target for cancer
treatment. Cell Death Dis. 4:e8382013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Levy JM and Thorburn A: Targeting
autophagy during cancer therapy to improve clinical outcomes.
Pharmacol Ther. 131:130–141. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu J, Fan L, Wang H and Sun G: Autophagy,
a double-edged sword in anti-angiogenesis therapy. Med Oncol.
33:102016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bhutia SK, Dash R, Das SK, Azab B, Su ZZ,
Lee SG, Grant S, Yacoub A, Dent P, Curiel DT, et al: Mechanism of
autophagy to apoptosis switch triggered in prostate cancer cells by
antitumor cytokine melanoma differentiation-associated gene
7/interleukin-24. Cancer Res. 70:3667–3676. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Park EJ, Kim SY, Kim SH, Lee CR, Kim IS,
Park JK, Lee SW, Kim BJ, Chun JN and Jeon JH: SK&F 96365
induces apoptosis and autophagy by inhibiting Akt-mTOR signaling in
A7r5 cells. Biochim Biophys Acta. 1813:2157–2164. 2011. View Article : Google Scholar : PubMed/NCBI
|
